Medicare
Annual Medicare Expense for Anti-VEGF Injections Tops $4 Billion, Study Finds
A significant rise ($1.5 billion more per year) can be attributed to greater uptake of aflibercept by retina specialists. Regional differences reflect local variation in disease burden.
02/21/2024
Age-related Eye Diseases Higher in Prevalence, Incidence Over 15 Years
While the trends reported represent small changes, due to the size of the US Medicare beneficiary population these differences equate to a large number of individuals and considerable economic cost.
07/26/2023
Lack of Eye Care Access in US Reflects Socioeconomic Trends
Patients with Medicare in areas that were rural, had lower household incomes or higher unemployment rates did not make significant use of available services.
05/30/2023
Upcoming Events
November 6, 2024
Showcasing Inflammation and IOP Control
Location: Prime 47
Presenters: Marc Bloomenstein, OD, and Nora Lee Cothran, OD
Time: 7:00pm ET
Sponsored by Bausch + Lomb
November 7, 2024
Racing Ahead: An Engaging Experience with a Trackside Challenge
Location: Commission Row
Presenters: Crystal Brimer, OD, Mile Brujic, OD, and Gina Welsey, OD
Time: 7:30pm ET
Sponsored by Bausch + Lomb
November 8, 2024
XDEMVY Experts: Real-World Patient and OD Perspectives
Location: Commission Row
Presenters: Damon Dierker, OD, Ben Gaddie, OD, Selina McGee, OD, and Pam Theriot, OD
Time: 7:00pm ET
Sponsored by Tarsus
